News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Meredith Wadman, Nature News Blog | 02.08.2012
More than one report from an august body of experts has gathered dust in Washington DC.  But the Woodrow Wilson...
By Global News, Global News | 02.08.2012

TORONTO - Many couples struggling with infertility look to fertility-assisted reproductive technologies to conceive a child. When evaluating fertility clinics...

By Kim Carollo, ABC News | 02.03.2012

If you were at higher risk for developing a condition like Alzheimer's disease or breast cancer, would you want to...

By Kim Carollo, ABC News | 02.03.2012

If you were at higher risk for developing a condition like Alzheimer's disease or breast cancer, would you want to...

By Frances Cha, CNN | 02.02.2012
When Min Lee, 54, first toured Seoul's Chaum Life Center -- which is spearheading Korea's stem cell banking industry --...
By Frances Cha, CNN | 02.02.2012
When Min Lee, 54, first toured Seoul's Chaum Life Center -- which is spearheading Korea's stem cell banking industry --...
By Tony Dutra, Bloomberg BNA | 02.02.2012
Petitioners challenging the patent eligibility of isolated DNA filed a reply brief Jan. 20, rejecting the respondent patent owner's call...
By Tony Dutra, Bloomberg BNA | 02.02.2012
Petitioners challenging the patent eligibility of isolated DNA filed a reply brief Jan. 20, rejecting the respondent patent owner's call...